Simon Mure1, Charles Guttmann2, Thomas Grenier1, Hugues Benoit-Cattin1, and François Cotton3
1CREATIS, Villeurbanne cedex, France, 2Center for Neurological Imaging, Brigham and Women's Hospital, Boston, MA, United States, 3CREATIS - HCL, Villeurbanne cedex, France
Synopsis
In this paper, we take advantage of a
unique longitudinal MRI dataset acquired at weekly intervals on untreated
multiple sclerosis patients. We study the signal dynamics of
relapsing-remitting multiple sclerosis lesions on SWI MRI and show, thanks to
an unsupervised spatiotemporal clustering algorithm, that specific signal intensity behaviors exist between the veins and the lesions that are synchronous with
contrast enhancement on gadolinium-enhanced T1-weighted MRI. Our study shows
that vein narrowing depicted on SWI is an early event that appears to precede
blood-brain barrier disruption signified by contrast-enhancement.PURPOSE
Multiple sclerosis (MS)
is a disease of the central nervous system characterized by spatial and
temporal dissemination of demyelination, axonal loss, and gliosis. It is the
primary cause of non-traumatic disability in young patients, and its exact
pathophysiology remains unknown. Characteristically, lesions in the white
matter develop around a central vein1.
Susceptibility-weighted
imaging (SWI) can directly depict cerebral veins by exploiting venous blood
oxygenation2. No study has presented the dynamic interaction between
the veins and the occurrence and early evolution of new lesions in MS. We
describe dynamic changes in appearance of both the central vein and the
surrounding new lesions in a unique cohort of patients followed at weekly
intervals with a multimodal MR protocol3,4.
Furthermore,
we use an automated analysis method5 to quantify the observed dynamic
changes in the central vein.
METHODS
Five untreated
relapsing-remitting MS patients underwent 8 weekly 3T MR acquisitions4.
New lesions were detected on gadolinium-enhanced T1-weighted MRI as well as on
SWI MRI. SWI was used to describe changes in the appearance of lesion and
central vein during lesion formation.
Selection
criteria for studied MS lesions: (1) Contrast-enhancement appears after the
baseline acquisition and is no longer visible at the 8th time-point,
to ensure complete history of enhancement; (2) The veins on which the lesions
are centred must have a minimal diameter of 2 pixels.
The selected SWI
ROIs were processed with an unsupervised spatiotemporal clustering method5
in order to group pixels sharing similar intensity evolution patterns. No prior
knowledge about data behavior was used to initialize or guide the analysis.
RESULTS
101 lesions out
of 212 active lesions were enhancing after baseline and no longer enhancing at
week 8. Out of these, only three new enhancing lesions in 2 of the 5 patients
met the full inclusion criteria, enabling their characterization. In all three
lesions transient hyperintensity was observed on SWI within the central vein at
the time of enhancement. The automatic clustering obtained on each ROI
identified several evolution patterns within the lesions, with one occurring at
the lesion core between the veins and the white matter as shown in Fig.
1.
Moreover, it is
shown in Figures 2, 3 and 4 that the specific grey level behaviors at the vein/lesion
(V/L) interface occur either simultaneously to the lesion enhancement (ROI A)
or before lesion enhancement in the SWI acquisitions (ROI B, C). These
observations show the centrifugal development around a central vein of the
observed MS lesions on highly resolved temporal data, which is consistent with
previous work6.
DISCUSSION
The development
of MS lesions around the vein was observed in histology long time ago
especially by7,8. They first hypothesised a centrifugal lesion
development from the veins but they did not have access to the dynamic
evolution of MS lesions. With the advent of MRI, longitudinal measurements demonstrating
that lesions grow centrifugally were acquired6. Recently, vein size
modification concomitant to plaque formation was shown9.
Our results
suggest that a stenosis of the vein could be observed on SWI at the time of
enhancement on post-gadolinium T1. These findings are also supported by another
recent study making the hypothesis that the small apparent size of
intralesional MS veins may reflect compression by the perivascular inflammatory
cuff within active lesions or hardening of the vascular wall in chronic lesions9.
Given
that the intralesional vein narrowing does reverse at later time points, when
the lesion appears larger, it is unlikely that partial-voluming would determine
the intravascular hyperintensity.
Our study shows
that vein narrowing is an early event that appears to precede blood-brain
barrier disruption signified by contrast-enhancement. The
observed transient vein narrowing and intraveinous hyperintensity in active
lesions is consistent with previous cross-sectional findings9.
CONCLUSION
Intralesional
vein stenosis is reversible and consistent with focal hypercellularity in the
context of T-cell aggregation during MS lesion formation. Spatiotemporal
clustering enables automated detection of venular and lesional changes over
time. Our findings are not generalizable due to insufficient spatial
resolution, yielding only 3 analyzable lesions. Future work at high temporal
and spatial resolution is needed. Nevertheless, our
findings are a further step in the understanding of MS plaque formation, and
might guide future research into disrupting lesion formation at its earlier
stages.
Acknowledgements
This work was
funded by CNRS grant PEPS INS2I.
This work was performed within the framework of the LABEX
PRIMES (ANR-11-LABX-0063) of Université de Lyon, within the program
"Investissements d'Avenir" (ANR-11-IDEX-0007 / ANR-10-COHO-002)
operated by the French National Research Agency (ANR).
References
1. Ge Y, Law M, Herbert J, Grossman RI.
Prominent perivenular spaces in multiple sclerosis as a sign of perivascular
inflammation in primary demyelination. AJNR Am J Neuroradiol.
2005;26(9):2316-2319.
2. Haacke EM, Xu Y, Cheng YC, Reichenbach
JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612–618.
3. Cotton F, Weiner HL, Jolesz FA, Guttmann
CR. MRI contrast uptake in new lesions in relapsing-remitting MS followed at
weekly intervals. Neurology. 2003;60(4):640-6.
4. Guttmann CR, Rousset M, Roch JA, Hannoun
S, Durand-Dubief F, Belaroussi B, Cavallari M, Rabilloud M, Sappey-Marinier D,
Vukusic S, Cotton F. Multiple sclerosis lesion formation and early evolution
revisited: A weekly high-resolution magnetic resonance imaging study. Mult
Scler. 2015;1352458515600247
5. Mure S, Grenier T, Meier DS, Guttmann
CRG, Benoit-Cattin H, Unsupervised spatio-temporal filtering of image
sequences. A mean-shift specification. Pattern Recognition Letters.
2015;68:48-55.
6. Guttmann CR, Ahn
SS, Hsu L, Kikinis R, Jolesz FA. The evolution of multiple sclerosis lesions on
serial MR. AJNR Am J Neuroradiol. 1995 Aug;16(7):1481-91.
7. Dawson JD. The histology of disseminated
sclerosis. Trans. Roy. Soc. Edinburgh. 1916;50:517-740.
8. McAlpine D, Compston
ND, Lumsden CE. Pathology of multiple sclerosis. Edinburgh,
E & S Livingstone. 1955;208-239.
9. Gaitán MI, de Alwis MP, Sati P, Nair G,
Reich DS. Multiple sclerosis shrinks intralesional, and enlarges extralesional,
brain parenchymal veins. Neurology. 2013;80(2):145-51.